Peter Osborne joined Venclose in 2017 as Chief Financial Officer. Prior to joining Venclose, Mr. Osborne was an independent financial executive consultant serving life science and technology companies. He served as the Chief Financial Officer for MyoScience Inc. (pain management and esthetics), SentreHEART Inc. (structural heart), Hansen Medical Inc. (structural heart) and VNUS Medical Technologies Inc. (superficial vein reflux; acquired by Covidien). Mr. Osborne began his career with Deloitte & Touche LLP where he was an audit partner in their Technology Practice. Mr. Osborne currently serves on the Board of Directors for two companies. He is a CPA and CGMA and holds both a Bachelor of Science in Operations Research degree and Bachelor of Commerce in Finance and Statistics degree from the University of Cape Town (Cape Town, South Africa). He also completed the Stanford University Executive Institute Program sponsored by the American Electronics Association.
Sign up to view 0 direct reports
Get started